MedTrace Logo

Re-Trabeculectomy Versus Ahmed Glaucoma Valve Implantation in Secondary Surgical Management of Patients With Refractory Glaucoma

NCT01633775 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2012-07-04

No results posted yet for this study

Summary

The purpose of this study is to compare three-year outcomes of re-trabeculectomy with those of Ahmed glaucoma valve implantation in secondary surgical management of patients with primary open angle glaucoma (POAG) and a history of previous failed trabeculectomy.

Conditions

  • Refractory Primary Open Angle Glaucoma

Interventions

PROCEDURE

Implantation of Ahmed glaucoma tube shunt, and Trabeculectomy with MMC

In the Ahmed implant group, the tube shunts used were the valved 184-mm2 surface area (Model FP7; New World Medical, Inc, Rancho Cucamonga, California, USA). In the Trabeculectomy group, a routine trabeculectomy surgery was performed.

Sponsors & Collaborators

  • Vanak Eye Surgery Center

    lead OTHER

Principal Investigators

  • Nariman Nassiri, MD, MPH · Vanak Eye Surgery Center

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01633775 on ClinicalTrials.gov